122 related articles for article (PubMed ID: 18033003)
1. [A familial form of conduction defects associated with a PRKAG2 gene mutation].
Pochmalicki G; Genest M; Richard P; Komajda M; Charron P
Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003
[TBL] [Abstract][Full Text] [Related]
2. A familial form of conduction defect related to a mutation in the PRKAG2 gene.
Charron P; Genest M; Richard P; Komajda M; Pochmalicki G
Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151
[TBL] [Abstract][Full Text] [Related]
3. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
4. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
Hong K; Oliva A; Cheng XS; Brugada P; Brugada J; Sternick EB; Brugada R
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):552-4. PubMed ID: 17711718
[TBL] [Abstract][Full Text] [Related]
5. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R
N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343
[TBL] [Abstract][Full Text] [Related]
6. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
[TBL] [Abstract][Full Text] [Related]
8. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
10. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
[TBL] [Abstract][Full Text] [Related]
12. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
13. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
14. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
15. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
Gollob MH; Green MS; Tang AS; Roberts R
Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471
[TBL] [Abstract][Full Text] [Related]
16. Familial pseudo-Wolff-Parkinson-White syndrome.
Sternick EB; Oliva A; Magalhães LP; Gerken LM; Hong K; Santana O; Brugada P; Brugada J; Brugada R
J Cardiovasc Electrophysiol; 2006 Jul; 17(7):724-32. PubMed ID: 16836667
[TBL] [Abstract][Full Text] [Related]
17. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
Laforêt P; Richard P; Said MA; Romero NB; Lacene E; Leroy JP; Baussan C; Hogrel JY; Lavergne T; Wahbi K; Hainque B; Duboc D
Neuromuscul Disord; 2006 Mar; 16(3):178-82. PubMed ID: 16487706
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
[TBL] [Abstract][Full Text] [Related]
19. Human γ2-AMPK Mutations.
Yavari A; Sarma D; Sternick EB
Methods Mol Biol; 2018; 1732():581-619. PubMed ID: 29480501
[TBL] [Abstract][Full Text] [Related]
20. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]